{
  "test_info": {
    "models_tested": [
      "llama3.1:8b",
      "cniongolo/biomistral:latest",
      "qwen2.5:7b",
      "gemma2:9b"
    ],
    "ollama_url": "http://localhost:11434/v1",
    "timestamp": 1757350474.5404196
  },
  "data_collection": {
    "condition": "IBS",
    "requested_papers": 5,
    "papers_found": 5,
    "status": "success",
    "metadata_file": "C:\\Users\\samis\\Desktop\\MyBiome\\back_end\\data\\raw\\metadata\\pubmed_batch_1757350483.xml"
  },
  "model_results": {
    "llama3.1": {
      "model_name": "llama3.1:8b",
      "model_key": "llama3.1",
      "papers_processed": 4,
      "total_papers": 5,
      "failed_papers": [
        "39197422"
      ],
      "correlations_found": 8,
      "processing_time_seconds": 47.42552638053894,
      "input_tokens": 3260,
      "output_tokens": 1078,
      "correlations": [
        {
          "probiotic_strain": "Probiotics",
          "health_condition": "chronic constipation",
          "correlation_type": "inconclusive",
          "correlation_strength": null,
          "confidence_score": null,
          "study_type": null,
          "sample_size": null,
          "study_duration": null,
          "dosage": null,
          "supporting_quote": "Probiotics, bulk-forming laxatives, prokinetics, and Kampo medicines, for which there is insufficient evidence, are considered alternative or complementary therapy.",
          "paper_id": "39159626",
          "extraction_model": "llama3.1:8b"
        },
        {
          "probiotic_strain": "Saccharomyces boulardii CNCM I-745",
          "health_condition": "Clostridioides difficile infections",
          "correlation_type": "positive",
          "correlation_strength": 1.0,
          "confidence_score": 1.0,
          "study_type": "valid therapy",
          "sample_size": null,
          "study_duration": null,
          "dosage": null,
          "supporting_quote": "The use of probiotics, especially Saccharomyces boulardii CNCM I-745 have become valid forms of prevention therapy.",
          "paper_id": "39060738",
          "extraction_model": "llama3.1:8b"
        },
        {
          "probiotic_strain": "Limosilactobacillus reuteri DSM 17938",
          "health_condition": "infantile colic",
          "correlation_type": "positive",
          "correlation_strength": 1.0,
          "confidence_score": 1.0,
          "study_type": null,
          "sample_size": null,
          "study_duration": null,
          "dosage": null,
          "supporting_quote": "The strongest evidence exists for the use of Limosilactobacillus (L.) reuteri DSM 17938 and Bifidobacterium animalis subsp. lactis BB-12 for the treatment of infantile colic in breastfed infants.",
          "paper_id": "39060737",
          "extraction_model": "llama3.1:8b"
        },
        {
          "probiotic_strain": "Bifidobacterium animalis subsp. lactis BB-12",
          "health_condition": "infantile colic",
          "correlation_type": "positive",
          "correlation_strength": 1.0,
          "confidence_score": 1.0,
          "study_type": null,
          "sample_size": null,
          "study_duration": null,
          "dosage": null,
          "supporting_quote": "The strongest evidence exists for the use of Limosilactobacillus (L.) reuteri DSM 17938 and Bifidobacterium animalis subsp. lactis BB-12 for the treatment of infantile colic in breastfed infants.",
          "paper_id": "39060737",
          "extraction_model": "llama3.1:8b"
        },
        {
          "probiotic_strain": "Lacticaseibacillus rhamnosus GG",
          "health_condition": "irritable bowel syndrome",
          "correlation_type": "positive",
          "correlation_strength": 0.8,
          "confidence_score": 0.9,
          "study_type": null,
          "sample_size": null,
          "study_duration": null,
          "dosage": null,
          "supporting_quote": "Limited but yet encouraging evidence exists for Lacticaseibacillus rhamnosus GG (LGG) for the treatment of IBS",
          "paper_id": "39060737",
          "extraction_model": "llama3.1:8b"
        },
        {
          "probiotic_strain": "Limosilactobacillus reuteri DSM 17938",
          "health_condition": "functional abdominal pain",
          "correlation_type": "positive",
          "correlation_strength": 0.8,
          "confidence_score": 0.9,
          "study_type": null,
          "sample_size": null,
          "study_duration": null,
          "dosage": null,
          "supporting_quote": "Limited but yet encouraging evidence exists for L. reuteri DSM 17938 for the treatment of FAP",
          "paper_id": "39060737",
          "extraction_model": "llama3.1:8b"
        },
        {
          "probiotic_strain": "Bifidobacterium bifidum",
          "health_condition": "irritable bowel syndrome",
          "correlation_type": "positive",
          "correlation_strength": 0.65,
          "confidence_score": 0.78,
          "study_type": "meta_analysis",
          "sample_size": null,
          "study_duration": null,
          "dosage": null,
          "supporting_quote": "Some probiotics may be beneficial in irritable bowel syndrome (IBS),",
          "paper_id": "37541528",
          "extraction_model": "llama3.1:8b"
        },
        {
          "probiotic_strain": "Lactobacillus rhamnosus GG",
          "health_condition": "irritable bowel syndrome",
          "correlation_type": "positive",
          "correlation_strength": 0.72,
          "confidence_score": 0.85,
          "study_type": "RCT",
          "sample_size": 100,
          "study_duration": "8 weeks",
          "dosage": "10^9 CFU/day",
          "supporting_quote": null,
          "paper_id": "37541528",
          "extraction_model": "llama3.1:8b"
        }
      ]
    },
    "biomistral": {
      "model_name": "cniongolo/biomistral:latest",
      "model_key": "biomistral",
      "papers_processed": 0,
      "total_papers": 5,
      "failed_papers": [
        "39159626",
        "39060738",
        "39197422",
        "39060737",
        "37541528"
      ],
      "correlations_found": 0,
      "processing_time_seconds": 14.28867483139038,
      "input_tokens": 4159,
      "output_tokens": 53,
      "correlations": []
    },
    "qwen2.5": {
      "model_name": "qwen2.5:7b",
      "model_key": "qwen2.5",
      "papers_processed": 1,
      "total_papers": 5,
      "failed_papers": [
        "39159626",
        "39060738",
        "39197422",
        "37541528"
      ],
      "correlations_found": 4,
      "processing_time_seconds": 36.393423318862915,
      "input_tokens": 3292,
      "output_tokens": 652,
      "correlations": [
        {
          "probiotic_strain": "Limosilactobacillus reuteri DSM 17938",
          "health_condition": "infantile colic",
          "correlation_type": "positive",
          "correlation_strength": 0.8,
          "confidence_score": 0.9,
          "study_type": "RCT",
          "sample_size": null,
          "study_duration": null,
          "dosage": null,
          "supporting_quote": "The strongest evidence exists for the use of Limosilactobacillus (L.) reuteri DSM 17938 and Bifidobacterium animalis subsp. lactis BB-12 for the treatment of infantile colic in breastfed infants.",
          "paper_id": "39060737",
          "extraction_model": "qwen2.5:7b"
        },
        {
          "probiotic_strain": "Bifidobacterium animalis subsp. lactis BB-12",
          "health_condition": "infantile colic",
          "correlation_type": "positive",
          "correlation_strength": 0.8,
          "confidence_score": 0.9,
          "study_type": "RCT",
          "sample_size": null,
          "study_duration": null,
          "dosage": null,
          "supporting_quote": "The strongest evidence exists for the use of Limosilactobacillus (L.) reuteri DSM 17938 and Bifidobacterium animalis subsp. lactis BB-12 for the treatment of infantile colic in breastfed infants.",
          "paper_id": "39060737",
          "extraction_model": "qwen2.5:7b"
        },
        {
          "probiotic_strain": "Lacticaseibacillus rhamnosus GG (LGG)",
          "health_condition": "irritable bowel syndrome",
          "correlation_type": "positive",
          "correlation_strength": 0.6,
          "confidence_score": 0.7,
          "study_type": "RCT",
          "sample_size": null,
          "study_duration": null,
          "dosage": null,
          "supporting_quote": "Limited but yet encouraging evidence exists for Lacticaseibacillus rhamnosus GG (LGG) for the treatment of IBS and L. reuteri DSM 17938 for FAP.",
          "paper_id": "39060737",
          "extraction_model": "qwen2.5:7b"
        },
        {
          "probiotic_strain": "Limosilactobacillus reuteri DSM 17938",
          "health_condition": "functional abdominal pain (FAP)",
          "correlation_type": "positive",
          "correlation_strength": 0.6,
          "confidence_score": 0.7,
          "study_type": "RCT",
          "sample_size": null,
          "study_duration": null,
          "dosage": null,
          "supporting_quote": "Limited but yet encouraging evidence exists for Lacticaseibacillus rhamnosus GG (LGG) for the treatment of IBS and L. reuteri DSM 17938 for FAP.",
          "paper_id": "39060737",
          "extraction_model": "qwen2.5:7b"
        }
      ]
    },
    "gemma2": {
      "model_name": "gemma2:9b",
      "model_key": "gemma2",
      "papers_processed": 4,
      "total_papers": 5,
      "failed_papers": [
        "39159626"
      ],
      "correlations_found": 8,
      "processing_time_seconds": 97.13503122329712,
      "input_tokens": 3294,
      "output_tokens": 1058,
      "correlations": [
        {
          "probiotic_strain": "Saccharomyces boulardii CNCM I-745",
          "health_condition": "Clostridioides difficile infections",
          "correlation_type": "positive",
          "correlation_strength": null,
          "confidence_score": null,
          "study_type": null,
          "sample_size": null,
          "study_duration": null,
          "dosage": null,
          "supporting_quote": "The use of probiotics, especially Saccharomyces boulardii CNCM I-745 have become valid forms of prevention therapy.",
          "paper_id": "39060738",
          "extraction_model": "gemma2:9b"
        },
        {
          "probiotic_strain": "probiotics",
          "health_condition": "chronic diarrhea",
          "correlation_type": "positive",
          "correlation_strength": null,
          "confidence_score": null,
          "study_type": null,
          "sample_size": null,
          "study_duration": null,
          "dosage": null,
          "supporting_quote": "The first medicines to be considered for oral treatment are probiotics for regulating the gut microbiome and anti-diarrheals.",
          "paper_id": "39197422",
          "extraction_model": "gemma2:9b"
        },
        {
          "probiotic_strain": "Limosilactobacillus (L.) reuteri DSM 17938",
          "health_condition": "infantile colic",
          "correlation_type": "positive",
          "correlation_strength": 0.8,
          "confidence_score": 0.9,
          "study_type": null,
          "sample_size": null,
          "study_duration": null,
          "dosage": null,
          "supporting_quote": "The strongest evidence exists for the use of Limosilactobacillus (L.) reuteri DSM 17938 and Bifidobacterium animalis subsp. lactis BB-12 for the treatment of infantile colic in breastfed infants.",
          "paper_id": "39060737",
          "extraction_model": "gemma2:9b"
        },
        {
          "probiotic_strain": "Bifidobacterium animalis subsp. lactis BB-12",
          "health_condition": "infantile colic",
          "correlation_type": "positive",
          "correlation_strength": 0.8,
          "confidence_score": 0.9,
          "study_type": null,
          "sample_size": null,
          "study_duration": null,
          "dosage": null,
          "supporting_quote": "The strongest evidence exists for the use of Limosilactobacillus (L.) reuteri DSM 17938 and Bifidobacterium animalis subsp. lactis BB-12 for the treatment of infantile colic in breastfed infants.",
          "paper_id": "39060737",
          "extraction_model": "gemma2:9b"
        },
        {
          "probiotic_strain": "Lacticaseibacillus rhamnosus GG (LGG)",
          "health_condition": "irritable bowel syndrome",
          "correlation_type": "positive",
          "correlation_strength": 0.6,
          "confidence_score": 0.7,
          "study_type": null,
          "sample_size": null,
          "study_duration": null,
          "dosage": null,
          "supporting_quote": "Limited but yet encouraging evidence exists for Lacticaseibacillus rhamnosus GG (LGG) for the treatment of IBS",
          "paper_id": "39060737",
          "extraction_model": "gemma2:9b"
        },
        {
          "probiotic_strain": "Limosilactobacillus (L.) reuteri DSM 17938",
          "health_condition": "functional abdominal pain",
          "correlation_type": "positive",
          "correlation_strength": 0.5,
          "confidence_score": 0.6,
          "study_type": null,
          "sample_size": null,
          "study_duration": null,
          "dosage": null,
          "supporting_quote": "Limited but yet encouraging evidence exists for Lacticaseibacillus rhamnosus GG (LGG) for the treatment of IBS and L. reuteri DSM 17938 for FAP.",
          "paper_id": "39060737",
          "extraction_model": "gemma2:9b"
        },
        {
          "probiotic_strain": "...",
          "health_condition": "irritable bowel syndrome",
          "correlation_type": "positive",
          "correlation_strength": null,
          "confidence_score": null,
          "study_type": "meta_analysis",
          "sample_size": null,
          "study_duration": null,
          "dosage": null,
          "supporting_quote": "Some probiotics may be beneficial in irritable bowel syndrome (IBS)",
          "paper_id": "37541528",
          "extraction_model": "gemma2:9b"
        },
        {
          "probiotic_strain": "...",
          "health_condition": "irritable bowel syndrome",
          "correlation_type": "inconclusive",
          "correlation_strength": null,
          "confidence_score": null,
          "study_type": "meta_analysis",
          "sample_size": null,
          "study_duration": null,
          "dosage": null,
          "supporting_quote": "differences in species and strains used, as well as endpoints reported, have hampered attempts to make specific recommendations as to which should be preferred",
          "paper_id": "37541528",
          "extraction_model": "gemma2:9b"
        }
      ]
    }
  },
  "comparison": {
    "total_unique_strains_all_models": 11,
    "strains_found_by_all_models": 0,
    "common_strains_list": [],
    "model_strain_counts": {
      "llama3.1": 7,
      "biomistral": 0,
      "qwen2.5": 3,
      "gemma2": 6
    },
    "model_correlation_counts": {
      "llama3.1": 8,
      "biomistral": 0,
      "qwen2.5": 4,
      "gemma2": 8
    },
    "pairwise_comparisons": {
      "llama3.1_vs_biomistral": {
        "model1": "llama3.1:8b",
        "model2": "cniongolo/biomistral:latest",
        "common_strains": 0,
        "total_unique_strains": 7,
        "agreement_percentage": 0.0,
        "model1_only": 7,
        "model2_only": 0
      },
      "llama3.1_vs_qwen2.5": {
        "model1": "llama3.1:8b",
        "model2": "qwen2.5:7b",
        "common_strains": 2,
        "total_unique_strains": 8,
        "agreement_percentage": 25.0,
        "model1_only": 5,
        "model2_only": 1
      },
      "llama3.1_vs_gemma2": {
        "model1": "llama3.1:8b",
        "model2": "gemma2:9b",
        "common_strains": 2,
        "total_unique_strains": 11,
        "agreement_percentage": 18.181818181818183,
        "model1_only": 5,
        "model2_only": 4
      },
      "biomistral_vs_qwen2.5": {
        "model1": "cniongolo/biomistral:latest",
        "model2": "qwen2.5:7b",
        "common_strains": 0,
        "total_unique_strains": 3,
        "agreement_percentage": 0.0,
        "model1_only": 0,
        "model2_only": 3
      },
      "biomistral_vs_gemma2": {
        "model1": "cniongolo/biomistral:latest",
        "model2": "gemma2:9b",
        "common_strains": 0,
        "total_unique_strains": 6,
        "agreement_percentage": 0.0,
        "model1_only": 0,
        "model2_only": 6
      },
      "qwen2.5_vs_gemma2": {
        "model1": "qwen2.5:7b",
        "model2": "gemma2:9b",
        "common_strains": 2,
        "total_unique_strains": 7,
        "agreement_percentage": 28.57142857142857,
        "model1_only": 1,
        "model2_only": 4
      }
    },
    "model_strain_details": {
      "llama3.1": [
        "Saccharomyces boulardii CNCM I-745",
        "Bifidobacterium bifidum",
        "Bifidobacterium animalis subsp. lactis BB-12",
        "Probiotics",
        "Limosilactobacillus reuteri DSM 17938",
        "Lacticaseibacillus rhamnosus GG",
        "Lactobacillus rhamnosus GG"
      ],
      "biomistral": [],
      "qwen2.5": [
        "Limosilactobacillus reuteri DSM 17938",
        "Lacticaseibacillus rhamnosus GG (LGG)",
        "Bifidobacterium animalis subsp. lactis BB-12"
      ],
      "gemma2": [
        "Saccharomyces boulardii CNCM I-745",
        "Bifidobacterium animalis subsp. lactis BB-12",
        "Limosilactobacillus (L.) reuteri DSM 17938",
        "probiotics",
        "...",
        "Lacticaseibacillus rhamnosus GG (LGG)"
      ]
    }
  },
  "summary": {
    "best_correlations_extractor": {
      "model": "llama3.1",
      "correlations_found": 8
    },
    "best_strain_identifier": {
      "model": "llama3.1",
      "unique_strains_found": 7
    },
    "fastest_processor": {
      "model": "biomistral",
      "processing_time_seconds": 14.28867483139038
    },
    "total_unique_relationships": 11,
    "consensus_relationships": 0
  },
  "metadata": {
    "test_timestamp": 1757350710.7557745,
    "test_date": "2025-09-08 17:58:30",
    "python_version": "3.10.16 | packaged by Anaconda, Inc. | (main, Dec 11 2024, 16:19:12) [MSC v.1929 64 bit (AMD64)]",
    "ollama_base_url": "http://localhost:11434/v1",
    "models_tested": [
      "llama3.1:8b",
      "cniongolo/biomistral:latest",
      "qwen2.5:7b",
      "gemma2:9b"
    ]
  }
}